Effect of the protease inhibitor Trasylol on cholinesterase levels and on susceptibility to succinylcholine.
D000818:Animals; D007611:Aprotinin / Q000494:pharmacology*; D001921:Brain / Q000187:drug effects / Q000201:enzymology; D002802:Cholinesterases / Q000032:analysis*; D004285:Dogs; D007668:Kidney / Q000187:drug effects / Q000201:enzymology; D007928:Lethal Dose 50; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009132:Muscles / Q000187:drug effects / Q000201:enzymology; D012119:Respiration / Q000187:drug effects; D013390:Succinylcholine / Q000494:pharmacology* / Q000633:toxicity
D007611:Aprotinin; D002802:Cholinesterases; D013390:Succinylcholine